APOE and Alzheimer disease: In this sample of clinically and pathologically characterized patients with early AD aged less than 75 years, APOE4 carriers with BCHE-K had a mean age-at-diagnosis of AD 6.4 years earlier than in APOE4 carriers without BCHE-K (Fig. 1A).